The Renal Hemodynamic Effect of SGLT2 Inhibition in Patients With Type 1 Diabetes

Study Questions:

What is the impact of 8 weeks of treatment with sodium glucose cotransporter 2 (SGLT2) inhibition with empagliflozin 25 mg once daily on renal hyperfiltration, in type 1 diabetic patients?